LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
© LexDana · beta
LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged solar power · clear

ITC / Section 337

The Solar IP Landscape in the u.s. And China Is Heating Up

Written by : Michael E. Salamy Key Takeaway : Recent developments in the U.S. and China highlight that strong patent strategy and IP risk management are critical for companies operating in the solar supply chain. In March 2026, the U.S. International Trade…

May 26, 2026·ITC / Section 337·1 min read
PTAB

Ptab Considers What Constitutes by Another Under 102 E in Determining Whether Challenged Claims Are Unpatentable

Written by Benjamin Anger and Vikas Bhargava In a final written decision in Duncan Parking Tech., Inc. v. IPS Group Inc., IPR2016-00067, Paper 29 (P.TA.B. Mar. 27, 2017), the PTAB evaluated whether a prior art reference alleged to anticipate the challenged…

March 31, 2017·PTAB·2 min read
Data: FDA Orange & Purple Books · prosecution & litigation metadata · read-only.